1. Home
  2. QUAD vs RCKT Comparison

QUAD vs RCKT Comparison

Compare QUAD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$9.64

Market Cap

438.3M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.36

Market Cap

394.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
RCKT
Founded
1971
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.3M
394.2M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
QUAD
RCKT
Price
$9.64
$3.36
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
$9.93
$29.73
AVG Volume (30 Days)
341.3K
1.5M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
5.71%
N/A
EPS Growth
150.47
26.37
EPS
0.13
0.66
Revenue
$2,419,900,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$64.28
P/E Ratio
$73.08
$4.95
Revenue Growth
N/A
N/A
52 Week Low
$5.12
$2.53
52 Week High
$11.15
$5.45

Technical Indicators

Market Signals
Indicator
QUAD
RCKT
Relative Strength Index (RSI) 41.62 43.98
Support Level $7.15 $3.06
Resistance Level $11.01 $3.65
Average True Range (ATR) 0.37 0.21
MACD -0.12 -0.04
Stochastic Oscillator 17.18 18.79

Price Performance

Historical Comparison
QUAD
RCKT

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: